Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

2.

Sensitization to cocaine in the nigrostriatal dopamine system.

Zahniser NR, Peris J, Dwoskin LP, Curella P, Yasuda RP, O'Keefe L, Boyson SJ.

NIDA Res Monogr. 1988;88:55-77. Review.

PMID:
3145458
3.

Prenatal amphetamine effects on behavior: possible mediation by brain monoamines.

Middaugh LD.

Ann N Y Acad Sci. 1989;562:308-18. Review.

PMID:
2662861
4.

Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections.

Seiden LS, Commins DL, Vosmer G, Axt K, Marek G.

Ann N Y Acad Sci. 1988;537:161-72. Review.

PMID:
3059922
5.

[Neurochemical and neurophysiological organization of phenamine behavioral stereotypy (review of the literature)].

Arushanian EB.

Farmakol Toksikol. 1977 Mar-Apr;40(2):221-30. Review. Russian. No abstract available.

PMID:
404184
6.

Peculiar response of adolescent mice to acute and chronic stress and to amphetamine: evidence of sex differences.

Laviola G, Adriani W, Morley-Fletcher S, Terranova ML.

Behav Brain Res. 2002 Mar 10;130(1-2):117-25. Review.

PMID:
11864727
7.

Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.

Yui K, Ikemoto S, Ishiguro T, Goto K.

Ann N Y Acad Sci. 2000 Sep;914:1-12. Review.

PMID:
11085303
8.

[beta-Phenylethylamine and amphetamine: similar aspects in their behavioropharmacological and neurochemical characteristics].

Hirano M, Uchimura H, Shiraishi A, Kuroki T, Matsumoto T, Tsutsumi T.

Yakubutsu Seishin Kodo. 1989 Dec;9(4):335-48. Review. Japanese.

PMID:
2698018
9.

Intermittent Dopaminergic stimulation causes behavioral sensitization in the addicted brain and parkinsonism.

Fornai F, Biagioni F, Fulceri F, Murri L, Ruggieri S, Paparelli A.

Int Rev Neurobiol. 2009;88:371-98. doi: 10.1016/S0074-7742(09)88013-6. Review.

PMID:
19897084
10.

Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.

Glowinski J.

Res Publ Assoc Res Nerv Ment Dis. 1975;54:233-46. Review. No abstract available.

PMID:
769114
11.

Conditioning as a critical determinant of sensitization induced by psychomotor stimulants.

Pert A, Post R, Weiss SR.

NIDA Res Monogr. 1990;97:208-41. Review.

PMID:
1978927
12.

Brain monoamines and parkinsonism.

Hornykiewicz O.

Natl Inst Drug Abuse Res Monogr Ser. 1975 Nov;(3):13-21. Review.

PMID:
787796
13.

Dopaminergic mechanisms in idiopathic and drug-induced psychoses.

Lieberman JA, Kinon BJ, Loebel AD.

Schizophr Bull. 1990;16(1):97-110. Review.

PMID:
2185538
14.

The actions of amphetamine on neurotransmitters: a brief review.

Moore KE.

Biol Psychiatry. 1977 Jun;12(3):451-62. Review.

PMID:
17437
15.

Dopaminergic agents and circling behaviour.

Dankova J, B├ędard P, Langelier P, Poirier LJ.

Gen Pharmacol. 1978;9(5):295-302. Review. No abstract available.

PMID:
212346
16.

Role of genotype in the adaptation of the brain dopamine system to stress.

Puglisi-Allegra S, Kempf E, Cabib S.

Neurosci Biobehav Rev. 1990 Winter;14(4):523-8. Review.

PMID:
2287492
17.

Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity.

Kita T, Miyazaki I, Asanuma M, Takeshima M, Wagner GC.

Int Rev Neurobiol. 2009;88:43-64. doi: 10.1016/S0074-7742(09)88003-3. Review.

PMID:
19897074
18.

Pharmacology of amineptine: synthesis and updating.

Garattini S, Mennini T.

Clin Neuropharmacol. 1989;12 Suppl 2:S13-8. Review.

PMID:
2698268
19.
20.

Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.

Hornykiewicz O.

Neuroscience. 1978;3(9):773-83. Review. No abstract available.

PMID:
30919

Supplemental Content

Support Center